Medicinal chemicals & botanical products Sample Contracts

AutoNDA by SimpleDocs
EXHIBIT 10.2
Registration Rights Agreement • June 4th, 2001 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
STOCK PURCHASE AGREEMENT BY AND AMONG TWINLAB CORPORATION, TWIN LABORATORIES INC., WILLIAM LOGUE, SHERI SEARS
Stock Purchase Agreement • September 4th, 1998 • Twinlab Corp • Medicinal chemicals & botanical products • New York
ESCROW AGREEMENT
Escrow Agreement • May 9th, 2006 • Argan Inc • Medicinal chemicals & botanical products • Connecticut
COMMON STOCK PURCHASE WARRANT
Bionutrics Inc • January 17th, 2001 • Medicinal chemicals & botanical products • Arizona
COMMON STOCK PURCHASE WARRANT SMART FOR LIFE, INC.
Smart for Life, Inc. • December 15th, 2023 • Medicinal chemicals & botanical products

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Sabby Volatility Warrant Master Fund, Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on June 4, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Smart for Life, Inc., a Nevada corporation (the “Company”), up to 327,410 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

RECITALS
Stock Purchase Agreement • May 17th, 2004 • Roo Group Inc • Medicinal chemicals & botanical products • New York
HAUSER, INC.
Agreement and Plan of Merger • June 21st, 1999 • Zuellig Group N a Inc • Medicinal chemicals & botanical products • New York
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 24th, 2023 • Bright Green Corp • Medicinal chemicals & botanical products • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of May 21, 2023, between Bright Green Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

SUPPLEMENTAL INDENTURE ----------------------
Supplemental Indenture • March 18th, 1999 • Global Health Sciences Inc • Medicinal chemicals & botanical products • New York
ARTICLE I DEFINITIONS
Securities Purchase Agreement • January 2nd, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
RECITALS
Purchase and Sale Agreement • March 16th, 2006 • Bionutrics Inc • Medicinal chemicals & botanical products
AGREEMENT
Rights Agreement • September 14th, 2006 • Synovics Pharmaceuticals • Medicinal chemicals & botanical products • Delaware
AutoNDA by SimpleDocs
1- 2 substitutions and other variations as required or permitted by this Warrant Agreement (the "Warrant Certificate").
Warrant Agreement • January 17th, 2001 • Bionutrics Inc • Medicinal chemicals & botanical products • New York
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • May 24th, 2023 • Bright Green Corp • Medicinal chemicals & botanical products

This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 24, 2023, between Bright Green Corporation, a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

GRAPHIC OMITED] PROGEN INDUSTRIES LIMITED UNDERWRITING AGREEMENT SIGNED FOR PROGEN LISTED OPTIONS BRISBANE, AUSTRALIA MONDAY MAY 16, 2005 Progen Industries Limited (ASX: PGL, NASDAQ: PGLAF) today announced that it has signed an Underwriting Agreement...
Underwriting Agreement • May 17th, 2005 • Progen Industries LTD • Medicinal chemicals & botanical products

BRISBANE, AUSTRALIA MONDAY MAY 16, 2005 Progen Industries Limited (ASX: PGL, NASDAQ: PGLAF) today announced that it has signed an Underwriting Agreement in relation to the ASX listed Options expiring on 31 May 2005 with Emerging Growth Capital Pty Limited, (eG Capital). Accordingly, and provided all conditions of the Underwriting Agreement are met, eG Capital will take up any shortfall that exists if any of the listed Options (ASX:PGLO) remain unexercised following the expiry date.

ARTICLE I GRANT OF SECURITY INTEREST
Security Agreement • May 26th, 2006 • Synovics Pharmaceuticals • Medicinal chemicals & botanical products • New York
RAVEN SUB, INC.
Agreement and Plan of Reorganization • July 10th, 1998 • D&f Industries Inc • Medicinal chemicals & botanical products • California
EXHIBIT 16.1 SHARE PURCHASE AGREEMENT THIS AGREEMENT made the 31st day of March, 2004. BETWEEN: BIO-ONE CORPORATION
Share Purchase Agreement • April 15th, 2004 • Bio One Corp • Medicinal chemicals & botanical products • Ontario
LEASE
Lease • January 13th, 1999 • Fountain Pharmaceuticals Inc • Medicinal chemicals & botanical products • Florida
BIONUTRICS, INC. 2415 E. CAMELBACK RD., STE. 700 PHOENIX, AZ 85022
Letter Agreement • January 30th, 2006 • Bionutrics Inc • Medicinal chemicals & botanical products • New Jersey

This letter agreement serves as an amendment to the Technology License Agreement (the "Agreement") dated as of March 16, 2005 by and between Nostrum Pharmaceuticals, Inc. ("Nostrum") and Bionutrics, Inc. ("Bionutrics"), all on the terms and conditions hereinafter set forth. All terms defined in the Agreement shall have the same meanings in this letter agreement, unless otherwise specifically modified in this letter agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!